OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← Chilterns Neuro Centre Ltd

2024-12-31-accounts

ANNUAL REPORT 2024

Registered Company Number: 02294557 (England & Wales) Registered Charity Number: 800853

Contents

Page(s)

Contents P
Welcome from the Chair of Trustees 2
Member statistics 3
Report of the Trustees 4
How we are supported 5
Results of the member survey 9
Therapy services 11
Administrative details 13
Structure, governance and management 14
Louise’s story 16
Financial overview 17
Statement of the Trustee’s responsibilities 19
Sven’s story 20
Statement as to disclosure of information to auditors 21
Independent auditor’s report 22
Consolidated statement of financial activities 26
Consolidated balance sheet 27
Consolidates cash flow statement 28
Notes to the consolidated cash flow statement 29
Notes to the financial statement 30

==> picture [475 x 238] intentionally omitted <==

----- Start of picture text -----
Coming to the Centre changed my life, and
with everyone’s support I gradually got
some of my enthusiasm back. I started to
become the ‘old/new’ Sam.
Sam Purvis
Centre Member
----- End of picture text -----

1

Welcome to the Chilterns Neuro Centre Report of the Trustees for the Year Ended 31 December 2024

As I reflect on 2024, I am filled with immense pride at what the Chilterns Neuro Centre has accomplished in what has been a truly remarkable year of growth and community impact. Building on the successful expansion we achieved in 2023 when we opened our services to people with Parkinson's and stroke survivors alongside our MS members, 2024 has seen us strengthen these relationships and reach even more people across our community. Our membership has grown to over 800 people, demonstrating the vital need for the specialised neurological support we provide.

This year has been marked by extraordinary community spirit and fundraising success. Our PopUp Art Weekend celebrated its 20th anniversary, raising an impressive £21,530 for the charity, while Run Prestwood generated an incredible £9,089 through the dedication of hundreds of runners. These events showcase not just the generosity of our supporters, but the strength of the community that has grown around the Centre.

The Centre continued to provide a comprehensive range of therapy services, from physiotherapy and hydrotherapy to counselling and occupational therapy, all delivered by our skilled team of professionals. We have enhanced our physiotherapy programmes, developed new group activities, and strengthened our counselling and wellbeing support. The feedback from our annual member survey demonstrates the profound impact of this work, with 98% of members stating they would recommend the Centre to others with neurological conditions.

This year marked an important milestone in our financial sustainability journey. After the planned investment in expanded services during 2023, we achieved a significant turnaround with a net income of £143,811 compared to a deficit of £150,725 in the previous year. This positive result demonstrates the effectiveness of our strategic planning and the generous support of our donors, supporters and the wider community.

I want to express my heartfelt gratitude to our incredible team of staff, Trustees and volunteers, who make our impact in the community possible. Our volunteers are the beating heart of our charity, contributing thousands of hours and bringing warmth and expertise to every aspect of our work.

Their commitment ensures that we can continue to provide life-enhancing treatments and create a welcoming, supportive environment for all our members and their families.

Liz Lawrence-Blake Chair of Trustees

2

Member Statistics 2024

==> picture [19 x 9] intentionally omitted <==

----- Start of picture text -----
600
----- End of picture text -----

==> picture [570 x 682] intentionally omitted <==

----- Start of picture text -----
500
TTTATT ATTA TATA TTT TATA TETRA O RTC e anne
beeneneteetenatenatenatetaPPT T TTT TTT TATA TTT TET TTT TATAtena tetatete ATTA ate eatTTT iittTTT
400
HeennenneeneenentteaPTT TTT T TATE TTT e ATTAtena TATA tet tenceA ATTA TTT
During 2024, the Centre Peennennenenenentttteteta
300
PETA TTT T TATE TTT ATTA TATEtena tetaA T TA TTTete
grew from 727
heennenneneneeenetetateta
members to 840.
PETA TTT T TATE TTT ATTA TATEten tet treatATTA TTTtitt
200
beennennceeneeeteetetetetaPETA TTT T TATE TTR ATTA TATEtet tcta tetT TTTritittTTT
100
685 members received direct
support from the Centre during
- - HeeeeneetnetnnttttteFETT T TATE TATA TTTTRA ETAT TATE TTTtte RATT
0 2024. On average, 369 members
MS Parkinson's Stroke Carer
were supported every month.
8000
6000
Our wide range of services
were accessed a total of
cole ee g Gres a - 4000 17,426 times during 2024.
hl) easa” oP Seee a
2000
mm9 oe oh es fae.
2 oboe. 2 ee
0
Ee Og D> go, ue 908
Ok >.ene e Opps
is
es+ eeewensies 4
<i a thont
= [a]
“The Centre has changed my life. Its network of people, carers
and support gives me purpose.”
Members access our services from all
across the region.
“Thanks to the Centre, I am able to manage my
condition in a way that is just not possible
elsewhere. It helps with both my physical, social
and mental wellbeing.”
Exercise ClassesPhysioOxygen TherapyTherapeutic LeisureComplementary TherapyOccupational TherapyClinical CounsellingNew Member AssessmentsSpeech/Language TherapyNutritionCarer Support
----- End of picture text -----

Kenny, Centre Member

Report of the Trustees: strategic report

Finance

Following our successful transition to a multi-condition Centre in 2023, our primary goal for 2024 was to consolidate this expansion while maintaining financial sustainability. We delivered a positive net surplus of £143,811, demonstrating the effectiveness of our multicondition expansion strategy.

Total income reached £1,421,103, representing a remarkable 36% increase from the previous year's £1,045,445. This growth was driven by exceptional performance across all income streams, particularly in donations and legacies which increased to £1,147,039 from £811,047 in 2023.

The financial result shows improved efficiency in our operations. This financial stability has enabled us to invest in staff training, development and wellbeing initiatives and enhance our service delivery across all neurological conditions we support.

Strategic Objectives Achieved in 2024

Risk Management

The Board continues to work closely with our Health and Safety adviser to monitor and mitigate operational risks. Key focus areas in 2024 included cybersecurity enhancement, clinical governance for our expanded services, and financial resilience planning.

Future Plans

Looking ahead to 2025-2027, we are developing a new strategic plan that will focus on sustainable growth, enhanced clinical outcomes measurement, and exploring opportunities to share our successful multi-condition model with other Centres in the neurological charity sector.

4

How we are supported

Our Income

The charity undertakes a broad range of fundraising activities, including events and sponsorship, applications to grant-making trusts, corporate, individual and community donations. All activities are in line with the Code of Fundraising Practice set by the Fundraising Regulator, of which the Centre is a member. Membership subscriptions Investment income (£20,955 | 1%) (£9,231 | 1%) Other fundraising & collections (£78,129 | 5%) Café & Merch + In Centre FR. ( £71,020 | 5%) Gift Aid (£40,850 | 3%) Integrated Care Boards (£67,000 | 5%) Oakwood Wellbeing Trusts & Foundations Ltd (£105,862 | 7%) (£686,282 | 48%) Major donors (£109,000 | 8%) Donations from members (£103,515 | 7%) ~~a~~ Corporate, other donations & legacies (£129,289 | 9%)

5

Fundraising

Corporate Support

Our corporate alliances generated over £69,000 in 2024, representing a 50% increase on the previous year. We are grateful to our established Corporate Friends who provide regular monthly support and we were delighted to welcome several new multi-year partnerships.

==> picture [477 x 286] intentionally omitted <==

----- Start of picture text -----
Our strategic associations with Ashridge Home Care, Steering Developments, and Hollister Incorporated
have continued to flourish during the year, and we have welcomed new associations with Better Mobility
and Laybrook, providing both financial support and collaborative opportunities that directly benefit our
members.
=
Individual giving and member donations
All services continue to be offered free of charge to members. However, many members do make
regular donations – along with our supporters – and this support remains absolutely crucial to
our operations.
Michael Harrison Jeanette Warner
Product Specialist, Laybrook Director, Better Mobility
“Both our organisations share a deep “Our whole company’s ethos is about good
commitment to supporting people in leading customer service and meeting people’s
more independent and fulfilling lives, and mobility needs, which aligns perfectly with
we look forward to working together to the values of the Centre. Between us we can
make a positive difference in our help people live life to the full.”
communities.”
----- End of picture text -----

While the cost of living continues to impact donation levels, we've seen an increase in the number of regular donors, with around 28% of members now making monthly contributions. Our legacy programme continues to develop, with new legacy pledges received during the year.

Trusts

Grants income in 2024 totalled £466,252 made up of £364,310 for specific projects and £101,942 in unrestricted funding. Our thanks go to all the grant-makers whose support we can acknowledge publicly:

Aims2Cure

6

Funding was received for the following projects:

We were particularly grateful for further instalments of our three-year grant from the National Lottery Community Fund’s Reaching Communities programme, to help fund our range of clinical services and treatments from 2023-2025, and to the Ernest Hecht Charitable Foundation for three significant grants to fund laptops for our therapists, a clinical alarm system and salaries for our Physiotherapy team.

We were also delighted to be chosen as one of the Edward Gostling Foundation’s Legacy Partners to receive a £230,000 Deed of Gift Restricted Fund from their spend-out programme. This is restricted to maintaining our reserves at three months’ expenditure for the next five years, to give our charity some much-needed financial stability in difficult economic times. The total gift is shown in our 2024 SOFA for accounting purposes. The gift has been invested into a managed Investment fund, to generate further funds over the restricted period.

Community and events

Community and events had another positive year raising £124,470 a slight increase on the previous year. Our Pop-Up Art Weekend celebrated its 20th anniversary and raised an impressive £21,530, while Run Prestwood generated an incredible £9,089.

The Charity Golf Day at Stocks Golf Club proved highly successful, along with our second year at the Astonbury Festival, and we benefited from £909 donated through our partnership with Runaway Racing. The growth in community-led fundraising demonstrates the strong local support for our work.

Legacy and in-memory

Legacy and in-memory gifts totalled £19,878 in 2024, a very similar figure to that of 2023. We have raised the profile of legacy giving through our communications and have been notified of several additional legacy pledges. These gifts provide crucial long-term sustainability for the Centre.

Oakwood Wellbeing Ltd

Oakwood Wellbeing Limited (OWL), our wholly-owned subsidiary, continued its strong performance in 2024. The company generated £105,862 in outside usage income, with net profits of £56,649 being gift-aided to the charity. Combined with service charges, OWL contributed £89,192 to the Centre's operations, demonstrating the continued value of maximising the use of our specialist facilities, and we have expanded our offering to include specialised training workshops for healthcare professionals.

Annual Member Survey 2024

95% of members stated they would recommend the Centre In total there were 261 responses, 32% of the Centre’s membership. The total number was an increase on last to someone with a neurological condition or their carer. year and the percentage of membership was the same.

99%

99% of members stated they would recommend the Centre to someone with a neurological condition or their carer.

91% of members agreed 91% the Centre helped manage their symptoms at least most of the time.

74%

74% of members agreed the Centre helped them stay active in the community at least most of the time.

93% of members agreed 93% the Centre helped improve their physical health at least most of the time.

86%

86% of members agreed the Centre helped maintain their independence at least most of the time.

90% of members agreed the Centre helped 90% improve their mental health at least most of the time.

82%

82% of members agreed the Centre helped increase their social contact and reduce feelings of loneliness at least most of the time.

“The Centre has been like a breath of fresh air to me and the support I’ve received from everyone has been second to none. The staff, volunteers and other members have all been so warm and supportive and it has made an incredible difference to my recovery.”

“It is a wonderfully supportive community and a centre of excellent clinical care.”.

“It is the missing piece to my jigsaw. I have friends - members and volunteers - and advice, encouragement and support.”

“The Centre is a great place, everyone is lovely and very welcoming and we are very grateful for the support we’ve been given.”

Our volunteers

We simply cannot operate the Chilterns Neuro Centre without our incredible team of volunteers who give their time so generously. We now have around 90 regular volunteers who collectively contribute over 12,000 hours every year.

Our volunteers are the beating heart of our charity, working across every aspect of our operations - from reception and café services to running specialised programmes like oxygen therapy, supporting fundraising events and providing administrative assistance.

"Volunteering at the Centre has enriched my life in ways I never expected. The resilience and positivity of our members inspires me every day, and knowing I'm contributing to their wellbeing gives me a tremendous sense of purpose."

Patricia Williams, Centre Volunteer

"I started volunteering after retiring, looking for something meaningful to do. Five years later, I can't imagine my week without my time at the Centre. The friendships I've made and the skills I've developed have been incredible."

David Thomson, Centre Volunteer

Many thanks to all our lovely volunteers for your wonderful loyalty to our charity and those who we support. twelve thousand 90

twelve thousand 90 volunteers hours approximate saving to the charity each year £146,000

approximate saving to the charity each year

Therapy services

The Centre has continued to provide a comprehensive range of clinical services to support members' physical and mental wellbeing. We follow NICE guidelines and our philosophy centres on empowering members to effectively self-manage their conditions while providing expert professional support.

Our therapy team, which also includes contractors and volunteers, includes specialists in physiotherapy, hydrotherapy, occupational therapy, acupuncture, clinical counselling, dietetics, speech and language therapy and massage therapy. All our clinicians have specialist neurological expertise and provide care in both individual and small group settings.

Service Highlights for 2024:

Multi-Condition Integration and Service Expansion: All services are now fully integrated across MS, Parkinson's and stroke member communities. We have strengthened relationships with specialist nurses and local support groups, while investing in condition-specific training for our team.

During January 2024 alone, we provided direct support to 351 of our members who accessed our services over 1,500 times, demonstrating the high demand for our expanded multi-condition services.

Growing Our Community Impact

2024 marked our first full year as the Chilterns Neuro Centre, having successfully rebranded from the Chilterns MS Centre in 2023. This transformation has enabled us to welcome many new members while honouring our 39-year heritage of supporting people with MS.

Expanded Reach

Our multi-condition approach has allowed us to support 840 members across three neurological conditions, creating a more diverse and vibrant community. The integration has been remarkably successful, with members across all conditions participating in shared activities and supporting each other.

Community Partnerships

We have developed new partnerships with:

Administrative details

Company details

Registered company number 02294557 (England and Wales) Registered charity number 800853 Registered office and principal address Chilterns Neuro Centre

Oakwood Close, Wendover, Aylesbury, Buckinghamshire. HP22 5LX

Telephone numbers

01296 696133 (Reception) 01296 823040 (Fundraising) 01296 823047 (Finance office) Website / Email www.chilternsneurocentre.org info@chilternsneurocentre.org

Social media

Trustees

Liz Lawrence-Blake (Chair) Ian Summerfield (resigned February 2025) Henry Snow (Treasurer) (resigned February 2025) John Bedford Robert Carter (resigned February 2025) Karen Cross (appt Vice Chair March 2025) Alison Heywood (resigned February 2025) Darayus Motivala Simon Turner

Company Secretary

Liz Lawrence-Blake LLB (Hons) barrister-at-law

Chief Executive

Richard Parkin

Leadership Team

Jody Barber - Head of Integrated Clinical Services Stella Kubale - Head of Fundraising Lou Grace - Deputy Head of Integrated Clinical Services Annette Cockroft - Deputy Head of Integrated Clinical Services (appt April 2024)

Eileen Inman - Finance Manager Andrew Scott - Communications Manager Dhiren Patel - Facilities Manager Jo Kendall - Oakwood and Clinical Administration Manager (appt January 2024)

Patrons

Trishna Bharadia BA (Hons) The Earl of Buckinghamshire Lord Carlile of Berriew KC Prof Gavin Giovannoni MBBCh PhD FCP FRCP FRCPath Derek K Townsend DL

Facebook: www.facebook.com/ ChilternsNeuro X: @ChilternsNeuro LinkedIn: ChilternsNeuro Instagram: @ChilternsNeuro

Auditors

Dux Advisory Limited Kennel Club House Gatehouse Way Aylesbury Buckinghamshire HP19 8DB

Bankers

National Westminster Bank Plc 22 Market Square Aylesbury Bucks HP20 1PR

Lloyds Bank Plc 79 High Street Chesham Buckinghamshire HP5 1DE

Santander 1st Floor Operations Block Bridle Road Bootle Merseyside L30 4GB

13

O

Structure, governance and management

Governing document

Chilterns Neuro Centre Ltd is registered with the Charity Commission for England and Wales and was incorporated as a company limited by guarantee on 9 September 1988. The charity is governed by its Articles of Association as amended at the Annual General Meeting held on 26 July 2018.

Organisational structure

The Board of Trustees is responsible for overall management and governance, meeting monthly to set strategic direction, agree on budgets, and monitor performance. Day-to-day management is delegated to Chief Executive Richard Parkin, supported by the Leadership Team.

Governance

The CEO and Chair meet regularly, with the Leadership Team providing monthly written reports to Trustees. Risk management, Human Resources, Health and Safety, and feedback from subcommittees form part of trustee meeting agendas.

Five Permanent Committees:

==> picture [476 x 238] intentionally omitted <==

----- Start of picture text -----
I am committed to my regular
exercise regime. It is not an
investment in exercise for the sake
of exercise, it is an investment in
my future self.
Jenny, Centre Member
----- End of picture text -----

14

Recruitment and appointment of new Trustees

O

The Board works to maintain an appropriate balance of skills, knowledge, and experience. All Trustees are elected by membership, with one-third retiring by rotation at the AGM. New Trustees receive induction, including governance information and role descriptions. The Board ensures balance between Trustees with direct experience of neurological conditions and those without, ensuring beneficiary interests are represented while maintaining objective decision-making.

Staff pay

Clinical staff pay is benchmarked to NHS Agenda for Change scales, while non-clinical staff salaries are benchmarked against similar positions in comparable charities. The Board approved a cost-of-living pay increase effective January 2024.

Risk management

The Board, CEO, and Leadership Team continuously review and monitor organisational risks, with specialist Health and Safety advice provided by our volunteer adviser.

Public benefit

The Trustees have complied with their duty to have regard to the guidance on public benefit published by the Charity Commission in exercising their duties or powers.

The activities of the charity are focused on providing significant support for those with MS, Parkinson’s and stroke survivors through treatment and therapy, informal advice and peer support.

Performance

The charity’s performance is monitored monthly using a range of activity reports and indicators. These inform the Board of Trustees and governance committees and enable the leadership team to measure performance against strategic objectives and inform future planning.

Work has begun on the strategic objectives for 2025-2027 with a completion date set for mid 2025.

Workplace pension

All eligible staff are enrolled in a workplace pension scheme and the charity made contributions in line with the statutory requirements.

Professional development and training

All employed clinical staff are supported by professional training as appropriate and appraisals.

Other staff are also supported if possible, to ensure their training needs are met and they develop additional skills within their roles. Training programmes for clinicians around the expansion to other conditions is ongoing.

15

Louise’s story

Louise Rivers can testify to how life can change in an instant. On Easter Sunday in 2020 she was relaxing at home with her family -, when she suddenly experienced pins and needles in her leg. She initially dismissed her symptoms, but she quickly deteriorated and within four minutes, her husband recognised that she was having a stroke.

At the age of 44, Louise found herself unable to look after her family and home, so her husband, who she calls an absolute superstar, quickly became main carer to her and her son, whilst maintaining his full-time job.

Following several weeks of treatment in hospital, Louise continued her recovery with the Bucks Early Discharge Support Team where one of its members introduced her to the then MS Centre. The Centre had recently begun a trial to open up its services to people with Parkinson’s and stroke survivors.

“I can honestly say that from my very first visit and assessment, I felt such a positive vibe at the Centre. A little spark of hope for my future was ignited for me that day, something I’d not felt since having my stroke.”

Since then, Louise hasn’t looked back and has tried many of the classes, treatments and therapies on offer at the Centre. “I’ve worked with so many of the amazing individuals in their incredibly diverse team.”

“The physios and staff who provide these classes are both supportive and knowledgeable, helping me push to increase my fitness. They somehow manage to make me smile during exercise, even on my ‘down’ days by making exercise fun.”

“Even when I’m struggling with my mobility, Centre staff use their knowledge and experience to help me adapt my approach so I can continue to engage in physical activity. I’ve received support from the physiotherapy team on a knee injury and have recently been having acupuncture to help with pain after hurting my back.”

“The staff have supported me through these issues and helped me to get back on track. This has been amazing and a definite boost to my mental wellbeing. On top of all this, I’ve even had a wonderful Indian head massage at the Centre, which was an absolute treat!”

“Visiting the Centre is definitely a huge highlight of my week. It’s a very special place and I am forever grateful for everyone there who supports me on my journey. I’ve gained so much and continue to do more than I ever expected by working with their truly amazing team.”

16

Financial overview

O

The main points of the results for 2024 are:

Income for the year continued the strong recovery that began in 2023, reaching £1.4 million - a 36% increase. This demonstrates the success of our diversified fundraising strategy and the continued support of our community as we establish ourselves as a multi-condition centre.

Income

The underlying income performance shows consistent growth as we recover from pandemic impacts and establish our expanded service model.

2022 2023 2024
Post-Covid
Recovery		 Multi-
Condition
Launch		 Established
Expansion
Total Income Reported £841k £1,045k £1,421k
Underlying Income £841k £1,045k £1,421k
+7% +24% +36%

The Oakwood Wellbeing Limited trading subsidiary continued strong performance, benefiting from increased facility rentals and expanded service offerings to external organisations.

Expenditure

Total expenditure increased to £1,277k from £1,196k in 2023, representing careful cost management while expanding services. Investment in additional clinical staff and enhanced facilities was largely offset by improved operational efficiency.

Cash flow

For the first time since our expansion began, we achieved a positive cash flow with income exceeding expenditure by £123k. Our cash reserves have strengthened to £497k, providing operational cover and positioning us well within our 3 - 6 months reserves policy.

Resource management

Our financial strategy continues to focus on sustainable service delivery and fundraising diversification. We successfully increased clinical capacity while maintaining our commitment to free services for all members.

Performance indicators

The proportion of expenditure on the provision of treatments has fallen in the year. Although expenditure in this area has increased, the larger increase in the fundraising division reflects the continuing investment in this area.

Fundraising multiple

Fundraising multiple
2023 2024
Fundraising Income £849k £945k
Fundraising Costs £243k £255k
Fundraising Multiple 3.5 3.7

2023 of every £1 78p on care and support

2024 77 of every £1 p on care and support

Reserves

The Group's total reserves at 31 December 2024 were £2,805k, of which £355k were restricted, leaving £2,450k of unrestricted general reserves. Free reserves reached £527k (£339k unrestricted), providing 3 months operational cover - within our reserves policy.

18

Statement of the Trustee’s responsibilities

The Trustees (who are also directors of the Chilterns Neuro Centre for the purposes of company law) are responsible for preparing the Trustees' Annual Report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Sven's story

Sven Kuster originally came across the Chilterns Neuro Centre by chance and has since become a huge advocate for the wonderful staff, beneficial programmes, encouragement and support he receives.

“At the Centre, I’m taking full advantage of all the classes on offer. Once I’d joined I had a course of physiotherapy and attended a series of workshops on Falls Prevention.

“I’ve since had acupuncture sessions and more recently some hydrotherapy. On top of all that, to improve my strength and balance, I take part in daily exercise classes either in person or via Zoom which really has made a difference, giving me far more confidence in myself when I’m moving around.

“I have nothing but praise for the Centre staff and was especially grateful when I received some urgent acupuncture and physio following a trapped nerve.

“The Falls Prevention course proved to be invaluable. As well as practical skills such as how to get up from a fall, I have learnt how to reduce my risk of having a fall by making simple changes to my home.

“The advice I received included removing clutter, wearing well-fitting shoes rather than socks to avoid slipping on floors, ensuring hallways and staircases are well-lit and rearranging my home to provide clear pathways and lessen climbing, bending and stretching too much.

“Before coming to the Centre I felt lost and didn’t have contact with any other people with MS. I now have so much more confidence when talking about my MS. I have made good friends who can truly understand and support me.

“Spending time with family and friends has always been a priority for me and, although I have lost a certain amount of independence, particularly being slightly restricted in what I can do and where I can go, I still hope to be able to travel sometime in the future.

“From originally having the Centre recommended to me, I am now the one recommending the Centre to others.

“My advice for anyone thinking about coming to the Centre is don’t wait.

“Go for it!

“The staff are really great and always make time for you and you’ll meet some wonderful people.”

20

Statement as to disclosure of information to auditors Insofar as the Trustees are aware: There is no relevant audit information of which the charitable company's auditor is unaware; and The trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information. Auditors Dux Advisory Ltd will be proposed for reappointment at the forthcoming Annual General Meeting. This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act relating to small companies. Approved by order of the board of trustees on 30 July 2025 C.IL..Q. ACC, Liz Lawrence-Blake Chair of Trustees I/(HILTERN5

Independent auditor’s report to the members and Trustees of Chilterns Neuro Centre Ltd.

Opinion

We have audited the financial statements of Chilterns Neuro Centre Ltd. (the ‘parent charitable company’) and its subsidiaries (the ‘group’) for the year ended 31 December 2024 in this report, which comprises a consolidated statement of financial activities, a consolidated balance sheet and a consolidated cash flow statement, and notes to the financial statements, including a summary of significant accounting policies, and the companies' balance sheet.

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report.

We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

22

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you, where:

Other information

The Trustees are responsible for the other information. The other information comprises the information included in the Trustees’ annual report, other than the financial statements and our auditor’s report thereon.Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

23

Matters on which we are required to report by exception

In light of our knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and the Charities Act 2011 require us to report to you if, in our opinion:

Responsibilities of Trustees

As explained more fully in the Trustees’ responsibilities statement set out in this report, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the group’s and parent charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed auditor under the Companies Act 2006 and section 151 of the Charities Act 2011 and report in accordance with those Acts.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities.This description forms part of our auditor’s report.

24

Use of our report This report is made solely to the charitable companrfs members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and to the charitable companvs trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charitable company's members and its Trustees those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body and the charitable company's Trustees as a body, for our audit work, for this report, or for the opinions we have formed. Mr S Brownsmith FCA Senior Statutory Auditor For and on behalf of Dux Advisory Ltd, Statutory Auditor Kennel Club House Gatehouse Way Aylesbury Buckinghamshire, HP19 8DB August 2025 Dux Advisory is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

CHILTERNS NEURO CENTRE LTD. CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING CONSOLIDATED INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2024

Notes
3
6
4
5
7
8
23
INCOME AND ENDOWMENTS FROM
Donations and legacies
Charitable activities
Provision of treatments, care and support
for people with MS, Parkinson's & Stroke
Other trading activities
Investment income
Total
EXPENDITURE ON
Raising funds
Charitable activities
Provision of treatments, care and support
for people with MS, Parkinson's & Stroke
Total
NET INCOME/(EXPENDITURE)
Transfers between funds
Net movement in funds
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD
23		 Unrestricted
Funds
£
559,729
66,996
197,837
9,231
833,793
292,353
667,509
959,862
(126,069)
44,940
(81,128)
2,531,324
2,450,196		 Restricted
Funds
£
587,310
0
0
0
587,310
0
317,431
317,431
269,879
(44,940)
224,939
130,002
354,941		 31.12.2024
Total funds
£
1,147,039
66,996
197,837
9,231
1,421,103
292,353
984,939
1,277,292
143,811
0
143,811
2,661,326
2,805,137		 31.12.2023
Total funds
£
811,047
66,996
165,443
1,959
1,045,445
261,408
934,762
1,196,170
(150,725)
0
(150,725)
2,812,051
2,661,326

The notes on pages 29-43 form part of these financial statements The notes on pages 29 to 44 form part of these financial statements.

The statement of financial activities includes all gains and losses recognised in the year.

All income and expenditure has arisen from continuing activities.

26

TERE ALANCE Group Charity 31.12.2023 31.12.2024 31.12.2023 31.12.2024 Notes FIXED ASSETS Tangib5e assets Investments 14 15 2,372,677 2,405,276 1,999 2.372,677 ioo 2,405,276 2,099 2,372,677 2,407,275 2,372,777 2,407.375 CURRENT ASSETS Stocks Debtors Cash at bank 16 17 2,144 102,991 497,254 4,436 43.363 373,904 2.144 126,394 454,201 4.436 148,223 268,541 602,389 421,703 582,739 421.200 CREDITOR5 Amounts falling due within one year 18 174,1441 157.8811 {55,2611 (57,8001 NET CURRENT ASSETS 528,245 363,822 527,478 363,400 TOTAL ASSETS LESS CURRENT LIABILITIES 2,900,922 2,771.097 2,900,255 2,770,776 CREDITORS Amounts falllng due after more than one year 19 195,796} 1109.7741 195,7961 1109,7741 NET ASSETS 2,805,126 2,661,323 2,804,459 2.661,002 FUNDS PRIOR YEAR RETAINED EARNINGS s￿LEMENT0F PRIOR YEAR RE BY GIFT AID Capital Unrestricted Restricted 23 322 2,440,196 364,943 2,531,324 130,002 2.439,527 364,943 2.531.000 130,002 TOTAL FUNDS 2,805,139 2,661,326 2,804,471 2,661,002 The flnanclal statements were approved and authorised for issue by the Board ofTrustee5 on slgned on its behalf by:" and were Liz Lawrence-Blake Trustee Karen Cross Trustee The notes on pages 29 to 44 form part of these financial statements.

CHILTERNS NEURO CENTRE LTD. CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

31.12.2024
Notes
£
Cash flows from operating activities:
Cash generated from operations
1
193,595
Interest paid
(8,592)
Net cash provided by / (used in) operating activities
185,003
Cash flows from investing activities:
Purchase of tangible fixed assets
(58,532)
Interest received
9,231
Net cash provided by / (used in) investing activities
(49,301)
Cash flows from financing activities:
Loan repayments in year
(12,355)
Net cash provided by / (used in) financing activities
(12,355)
Change in cash and cash equivalents in the reporting period
123,347
Cash and cash equivalents at the beginning of the reporting period
373,907
Cash and cash equivalents at the end of the reporting period
497,254		 31.12.2023
£
(83,330)
(8,762)
(92,092)
(34,643)
1,959
(32,684)
(11,775)
(11,775)
(136,550)
510,457
373,907

The notes on pages 29-43 form part of these financial statements The notes on pages 40 to 54 form part of these financial statements.

28

CHILTERNS NEURO CENTRE LTD. NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT FOR THE YEAR ENDED 31 DECEMBER 2024

1 RECONCILIATION OF NET INCOME/(EXPENDITURE) TO NET CASH FLOW FROM OPERATING ACTIVITIES

Donated professional services and donated facilities are
Adjustments for:
Depreciation charges
Interest received
Interest paid
(Increase)/decrease in stocks
(Increase)/decrease in debtors
Increase/(decrease) in current creditors excluding bank loans and overdrafts
Net cash provided by / (used in) operating activities
Net income/(expenditure) for the reporting period (as per the consolidated
statement of financial activities)		 31.12.2024
£
143,811
91,130
(9,231)
8,593
2,292
(59,628)
16,628
193,595		 31.12.2023
£
(150,725)
81,896
(1,959)
8,762
(1,948)
(19,521)
165
(83,330)

2 ANALYSIS OF CHANGES IN NET DEBT

Cash
Loans falling due within one year
Loans falling due after more than one year		 At
01.01.2024
£
373,907
(5,694)
(109,774)
258,439		 Cash
Flows
£
123,347
135,703
12,356		 Other
non cash
changes
£
(1,623)
1,623
0		 At
31.12.2024
£
497,254
(7,317)
(95,795)
394,142

29

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

1 STATUTORY INFORMATION

Chilterns Neuro Centre Ltd. is a private company limited by guarantee incorporated in England and Wales. The registered office is Oakwood Close, Wendover, Aylesbury, Buckinghamshire HP22 5LX.

The presentation currency of the financial statements is the Pound Sterling (£) and the financial statements are rounded to the nearest £.

2 ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ir e land (FRS 102) (issued in October 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and the Companies Act 2006.

Chilterns MS Centre Ltd. meets the definition of a public benefit entity under FRS102. The financial statements have been prepared under the historical cost convention with the exception of investments which are included at market value.

At the date of approving these financial statements the trustees believe the charity has sufficient resources to ensure continued operational existence for the foreseeable future. The financial statements have therefore been prepared on the basis that the charity is a going concern.

Preparation of consolidated financial statements

The consolidated financial statements incorporate those of the Chilterns MS Centre and its wholly owned subsidiary Oakwood Wellbeing Limited on a line by line basis. Details of the subsidiary results are given in note 15. As permitted by section 408 of the Companies Act 2006, the SOFA of the parent company is not presented as part of these financial statements.

Income

Governance costs include those related to the cost of governance of the charity and its assets and are primarily associated with the compliance with constitutional and statutory requirements.

Recognition of income from donations will be deferred if the donor has specified the donation must be spent in a future accounting period(s) or if certain conditions have been imposed which must be met before the charity has unconditional entitlement. The gift aid associated with a donation is recognised when the donation is received by the charity. Gifts in kind are included at valuation at the time of the gift.

Subscription income is recognised in the year to which it relates and deferred in so much as it relates to a subsequent period.

The charity receives grants from Integrated Care Boards which are accrued in accordance with calculations based on monthly clinical activity data provided.

For legacies, entitlement is taken as the earlier of the date on which either: the charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the estate that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the charity has been notified of the executor's intention to make a distribution. Where legacies have been notified to the charity, or the charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material. The charity was notified of a legacy for £100,000 during 2023, but due to probate delays and now estate asset liquidation the charity are not expecting to receive these funds until well in to 2026 at the earliest.

30

CHILTERNS MS CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

2 ACCOUNTING POLICIES - continued

Donated services and facilities

Donated professional services and donated facilities are recognised as income when the charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use by the charity of the item is probable and that economic benefit can be measured reliably. In accordance with the Charities SORP (FRS102), the general volunteer time of the charity's volunteers is not recognised.

On receipt, donated professional services and donated facilities are recognised on the basis of the value of the gift to the charity which is the amount the charity would have been willing to pay to obtain the services or facilities of equivalent economic benefit on the open market; a corresponding amount is then recognised in expenditure in the period of receipt.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Raising funds

Raising funds includes all expenditure incurred by the charity to raise funds for its charitable purposes and includes costs of all fundraising activities, events and non-charitable trading.

Charitable activities

The costs of charitable activities are those directly incurred in support of the charity's objectives and include the costs of running the building owned and used by the charity.

Governance costs

Governance costs include those related to the cost of governance of the charity and its assets and are primarily associated with the compliance with constitutional and statutory requirements.

Allocation and apportionment of costs

Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with use of the resources.

31

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

2 ACCOUNTING POLICIES - continued

Tangible fixed assets

Tangible assets are stated at cost less accumulated depreciation. The cost of minor additions or those below £500 are not capitalised. Depreciation is provided at the following annual rates in order to write off the cost of each asset, less estimated residual value, over its estimated useful life.

Freehold property Plant and machinery etc. Main pool Pool refurbishment Oxygen chamber

Stocks

Stocks are valued at the lower of cost and net realisable value on a FIFO basis after making due allowance for obsolete and slow moving items.

Taxation

The charity is exempt from corporation tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Designated funds are funds set aside by the trustees out of unrestricted general funds for specific future purposes or projects.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Leasing commitments

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

Cash and cash equivalents

Cash and cash equivalents include cash in hand and deposits held on call with the charity's banks.

32

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

2 ACCOUNTING POLICIES - continued

Financial instruments

The charity has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments. The trustees are of the opinion that the charity does not currently have any Financial Instruments falling within the definition of Section 12 of FRS 102.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and cash equivalents, are initially measured at transaction price including costs and are subsequently carried at amortised cost using the effective interest method. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price. Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. Financial liabilities classified as payable within one year are not amortised.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity's contractual obligations expire or are discharged or cancelled.

Critical accounting estimates and judgements

There have been no judgements made by the trustees in applying the accounting policies which have had a significant effect on the amounts recognised in the financial statements.

There have been no assumptions concerning the future, and other key sources of estimation uncertainty at the year end that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

3 DONATIONS AND LEGACIES

Donations from members
Gift aid
Other donations and legacies
Fundraising and collections		 Unrestricted
Funds
£
103,515
40,850
126,289
289,075
559,729		 Restricted
Funds
£
0
0
3,000
584,310
587,310		 31.12.2024
Total
£
103,515
40,850
129,289
873,385
1,147,039		 31.12.2023
Total
£
113,778
49,372
101,497
546,400
811,047

Other donations and legacies include £13,840 (2023: £17,549) being the value of goods and services donated to the charity during the year.

33

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

4 OTHER TRADING ACTIVITIES

Sales
Membership subscriptions
Outside usage
INVESTMENT INCOME
Bank interest receivable
INCOME FROM CHARITABLE ACTIVITIES
Contributions from Clinical Commissioning Groups
RAISING FUNDS
Raising donations, legacies and outside usage
Staff costs
Fundraising Events
Sundries
Travel & subsistence
Cost of goods sold
Interest payment to parent
Giftaid payment to parent
Service fee paid to parent		 31.12.2024
£
71,020
20,955
105,862
197,837
31.12.2024
£
9,231
31.12.2024
Provision of
treatments,
care and
support for
people with
MS,
Parkinson's
and stroke
£
66,996
31.12.2024
£
260,509
15,594
3,721
0
12,529
0
0
0
292,353		 31.12.2023
£
50,122
18,199
97,122
165,443
31.12.2023
£
1,959
31.12.2023
Provision of
treatments,
care and
support for
people with
MS,
Parkinson's
and stroke
£
66,996
31.12.2023
£
237,257
14,044
1,679
74
8,354
0
0
0
261,408

5 INVESTMENT INCOME

6 INCOME FROM CHARITABLE ACTIVITIES

7 RAISING FUNDS

34

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

8 CHARITABLE ACTIVITIES COSTS

Provision of treatments, care and
support for people with MS,
Parkinson's and stroke
9
SUPPORT COSTS
Management
Information
technology
£
£
Provision of treatments, care and
support for people with MS,
Parkinson's and stroke
185,507
23,113
Support costs, included in the above, are as follows:
Support Salaries
Social security
Pensions
Postage, printing and stationery
Travel
Sundries
IT costs
HR costs
Auditors' remuneration
10
NET INCOME/(EXPENDITURE)
Net income/(expenditure) is stated after charging/(crediting):
Auditors' remuneration
Depreciation - owned assets
Hire of plant and machinery
2023 comparatives		 r
 Direct
costs
£
765,419
Human
esources
£
2,092
720,669		 Support costs
(See note 9)
£
219,520
Governance
costs
£
8,808
31.12.2024
Provision of
treatments,
care and
support for
people with
MS,
Parkinson's
and stroke
£
157,114
10,434
4,488
7,752
11
5,708
23,113
2,092
8,808
219,520
31.12.2024
£
8,808
91,130
5,004
214,093		 Totals
£
984,939
Totals
£
219,520
31.12.2023
Provision of
treatments,
care and
support for
people with
MS,
Parkinson's
and stroke
£
157,311
10,433
3,459
5,927
283
11,299
17,946
2,397
5,038
214,093
31.12.2023
£
5,038
81,896
1,240
934,762		 Totals
£
984,939
934,762

10 NET INCOME/(EXPENDITURE)

35

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

11 TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2024 nor for the year ended 31 December 2023.

Trustees' expenses

There were no trustees' expenses paid for the year ended 31 December 2024 nor for the year ended 31 December 2023.

12 STAFF COSTS

31.12.2024 31.12.2023
£ £
Wages and salaries 817,686 720,147
Social security costs 64,585 59,468
Other pension costs 20,953 19,312
903,224 798,927
Therapy staff 31.12.2024
18		 31.12.2023
18
Fundraising staff 7 6
Facilities staff 2 2
Administrative staff 4 3
31 29
The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:
£60,001 - £70,000 31.12.2024
3		 31.12.2023
1
13 2023 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
INCOME AND ENDOWMENTS FROM Unrestricted
£		 Restricted
£		 Total funds
£
Donations and legacies 466,141 344,906 811,047
Charitable activities
Contributions from Clinical Commissioning Groups
The Integrated Care Board		 66,996 0 66,996
Other trading activities 165,443 0 165,443
Investment income 1,959 0 1,959
Total 700,539 344,906 1,045,445

36

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

13 2023 COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued

Unrestricted
funds		 Restricted
funds		 Total funds
EXPENDITURE ON £ £ £
Raising funds 238,055 0 238,055
Charitable activities
Provision of treatments, care and support for people with
MS, Parkinson's and stroke		 592,521 151,253 743,774
Total 830,576 151,253 981,829
NET INCOME/(EXPENDITURE)
Transfers between funds		 (135,328)
13,533		 (6,303)
(13,533)		 (141,631)
0
Governance costs include those related to the cost of gover (121,795) (19,836) (141,631)
RECONCILIATION OF FUNDS
Total funds brought forward		 2,910,672 43,010 2,953,682
TOTAL FUNDS CARRIED FORWARD 2,788,877 23,174 2,812,051
14 TANGIBLE FIXED ASSETS - CHARITY (ALSO COMPRISING THAT
COST
At 1 January 2024
Additions
Disposals		 OF THE GROUP)
Freehold
property
£
2,468,960
0
0		 Fixtures and
fittings
£
700,374
58,532
0		 Totals
£
3,169,334
58,532
0
At 31 December 2024 2,468,960 758,906 3,227,866
T
DEPRECIATION
At 1 January 2024
Charge for year
Disposals		 278,279
25,123
0		 485,779
66,008
0		 764,058
91,130
0
At 31 December 2024 303,402 551,787 855,188
NET BOOK VALUE
At 31 December 2024		 2,165,558 207,119 2,372,677
At 31 December 2023 2,190,681 214,595 2,405,276

37

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

FIXED ASSET INVESTMENTS
MARKET VALUE
Unlisted investment in subsidiary companies.
Other unlisted investments		 Group
31.12.2024
31.12.2023
£
£
0
0
0
1,999
0
1,999		 Charity
31.12.2024
31.12.2023
£
£
100
100
0
1,999
100
2,099

15 FIXED ASSET INVESTMENTS

Other unlisted investments comprised of a donated set of 4 commemorative platinum coins listed at their purchase price, these were disposed of during the year for a nominal amount.

Unlisted investment in subsidiary companies.

The charity holds 100 shares of £1 each in its wholly owned trading subsidiary company Oakwood Wellbeing Limited which was incorporated in the United Kingdom on 7 September 2016 (registration number 10363280). Profits from the subsidiary are paid to the charity under the gift aid payment scheme. A summary of the financial performance of the subsidiary for the period 1 January to 31 December 2024 (1 January to 31 December 2023) is:-

31.12.2024 31.12.2023

Income
Less direct operating expenditure
Less service charge from parent charity
Net profit
Total equity brought forward
Profit for the financial year
Amount gift aided to the charity - prior year profits
Amount gift aided to the charity - current year profits
Total equity carried forward		 £
105,862
(16,321)
(32,892)
56,649
220
56,649
0
(56,300)
569		 £
97,122
(10,999)
(22,000)
64,123
167
64,123
(70)
(64,000)
220

The net contribution Oakwood Wellbeing Limited made to the parent charity in the year was £89,192 (2023: £86,000) being the total of the service charge and gift aided profit.

16
STOCKS
Stocks
17
DEBTORS
Trade debtors
Prepayments and accrued income
Amounts owed by group undertakings		 Group
31.12.2024
31.12.2023
£
£
2,144
4,436
Group
14,863
26,924
88,126
16,439
0
0
102,989
43,363		 Charity
31.12.2024
31.12.2023
£
£
2,144
4,436
Charity
6,239
17,148
88,128
16,439
32,027
114,636
126,394
148,223

Funds received as agents

During the year the charity received £26,006 (2023: £18,485) as an agent for exhibitors at its annual art exhibition. The exhibitors donated £10,004 (2023: £6,785) in total to the charity and the charity therefore paid the balance of £16,002 (2023: £11,700) to the exhibitors.

38

CHILTERNSNEUROS CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

18 CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Group Charity Charity
31.12.2024 31.12.2023 31.12.2024 31.12.2023
£ £ £ £
Bank loans and overdrafts (see note 20) 7,317 5,694 7,317 5,694
Trade creditors 14,335 18,032 14,254 17,951
Social security and other taxes 26,451 20,353 26,451 20,353
Accruals and deferred income 26,029 13,802 7,227 13,802
74,132 57,881 55,249 57,800
Deferred income amounting to £3,469 (2023: £12,833) at the balance sheet date comprises grants received with
time related restrictions and membership income received in advance.
CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
Bank loans (see note 20) Group
31.12.2024
31.12.2023
£
£
95,796
109,774		 Charity
31.12.2024
31.12.2023
£
£
95,796
109,774
LOANS
An analysis of the maturity of loans is given below: Group Charity
Amounts falling due within one year on demand: 31.12.2024
£		 31.12.2023
£		 31.12.2024
£		 31.12.2023
£
Bank loans 7,317 5,694 7,317 5,694
Amounts falling due between two and five years:
Bank loans - 2-5 years 38,024 29,780 38,024 29,780
Amounts falling due in more than five years:
Bank loans more than 5 years by instalments 57,772 79,994 57,772 79,994

19 CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

20 LOANS

21 OPERATING LEASE COMMITMENTS - CHARITY (ALSO COMPRISING THAT OF THE GROUP)

Minimum lease payments fall due as follows:

Other operating leases
Expiring:
between two and five years		 31.12.2024
£
106,849
106,849		 31.12.2023
£
930
930

39

CHILTERNS NEURO CENTRE LTD.

NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

22 SECURED DEBTS - CHARITY (ALSO COMPRISING THAT OF THE GROUP)

The following secured debts are included within creditors:

31.12.2024
£
103,113		 31.12.2023
£
115,468

The bank loan is secured by two legal charges, the first being over the freehold property of the charity and all associated assets. The charity entered into a bank loan agreement for £475,000 in 2012 so as to finance its new building. This loan was restructured in 2012 at a value of £216,736 and is repayable over a period of 15 years commencing January 2015 at an interest rate of 2.75% above base rate. The trustees believe that the charity will receive sufficient donations to be able to repay this loan in line with its terms. The second legal charge is fixed and floating over the charity and all its assets present and future.

23 MOVEMENT IN FUNDS

Unrestricted funds
At 01.01.2024
Income
£
£
Group - General fund
2,531,324
833,793
Charity - General fund
2,531,000
816,331
Restricted funds - Charity (also comprising that of the Group)
At 01.01.2024
Income
£
£
Reception & Garden Furniture
1,567
0
Physiotherapy Equipment
17,344
14,125
Owens building infrastructure Fund
3,815
0
Occupational Therapy Fund
0
3,000
Hardship Fund
150
0
Allergan Fund
5,192
Aims2Cure Pilates Fund
2,844
14,400
(0)
Rothschild Wellbeing Fund
0
45,000
Leisure Group Fund
134
(0)
Physio salaries
12,439
112,601
Oxygen
1,517
5,500
National Lottery
75,000
150,000
St James
10,000
0
The Edward Gostling Fund
0
230,000
Ernest Hecht Fund
0
12,684
130,002
587,310
GROUP - TOTAL FUNDS
2,661,326
1,421,103
2,661,002
1,403,641		 Expenditure
£
(959,861)
(942,748)
Expenditure
£
0
0
0
(2,054)
(150)
0
(6,796)
(31,093)
(0)
(122,041)
(5,297)
(150,000)
0
0
0
(317,431)
)
(1,277,292)
(1,260,178)		 Transfers
£
44,940
44,940
Transfers
£
0
(31,125)
(3,815)
0
0
0
0
0
0
0
0
0
(10,000)
0
0
(44,940)
0
0		 At 31.12.2024
£
2,450,196
2,449,523
At 31.12.2024
£
1,567
344
(0)
946
0
5,192
10,448
13,907
134
2,999
1,720
75,000
0
230,000
12,684
354,941
2,805,137
2,804,471

The transfer between funds reflects expenditure on capital items in accordance with the terms of the fund.

40

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

23 MOVEMENT IN FUNDS - COMPARATIVES

Unrestricted funds
Charity - General fund
Restricted funds
Reception & Garden Furniture
Physiotherapy Equipment
Owens building infrastructure Fund
Hardship Fund
Oxygen
Pool Uv Filters
National Lottery Community Fund
Physio Salaries
Allergan Fund
Aims2Cure Pilates Fund
Rothchilds Wellbeing fund
Hobson Charity
Leisure / Therapy Group
St James'
GROUP - TOTAL FUNDS
CHARITY - TOTAL FUNDS		 At 01.01.2023
£
2,788,877
2,788,613
1,567
687
3,815
200
6,373
0
0
0
9,886
0
0
0
646
0
23,174
2,812,051
2,811,787		 Income
£
700,539
689,487
0
17,000
0
0
3,500
8,667
150,000
106,939
0
10,800
25,000
10,000
0
13,000
344,906
1,045,445
1,034,393		 Expenditure
£
(966,759)
(955,771)
0
(343)
0
(50)
(8,358)
0
(75,000)
(94,500)
(4,693)
(7,956)
(25,000)
(10,000)
(512)
(3,000)
(229,412)
(1,196,171)
(1,185,183)		 Transfers At 31.12.2023
£
£
8,667
2,531,324
8,667
2,531,000
0
1,567
0
17,344
0
3,815
0
150
0
1,517
(8,667)
0
0
75,000
0
12,439
0
5,192
0
2,844
0
0
0
0
0
134
0
10,000
(8,667)
130,002
#
0
2,661,326
0
2,661,002

The Reception & Garden Furniture Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the refit of the Centre reception area.

The Physiotherapy Equipment Fund relates to donations received by the charity where they wish for the funds to be applied towards the purchase of physiotherapy equipment.

The Occuptaional Therapy Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on Occupational therapy services.

The Hardship Fund relates to a donation received by the charity where the donor has agreed to support members unable to pay membership fees through financial hardship.

The Allergan Fund relates to a donation received by the charity where the donor has stated they wish for the donation to be spent on fundraising costs.

41

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

23 MOVEMENT IN FUNDS (CONTINUED)

The National Lottery Community Fund relates to donations received by the charity where the donor has stated they wish for the donations to be spent on the provision of physiotherapy services.

The Rothschild Wellbeing Fund relates to donations received by the charity where the donor has stated they wish the donations to be spent on the provision of wellbeing activities.

The Leisure Group Fund relates to donations received by the charity where the donor has stated they wish the donations to be spent on therapeutic leisure group activities.

The Physiotherapy Salaries Fund relates to donations received by the charity where the donors stated that the funds should be used to fund the provision of physiotherapy.

The Oxygen Supplies Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spent on the operational costs of the oxygen chamber.

The St James Fund relates to donations received by the charity where the donor has stated they wish for the donation to be spend on counselling.

The Edward Gostling Fund is an endowment fund that has been granted to meet operating costs of charitable activities should free reserves fall below 3 months of operational expenditure.

The Ernest Hecht Fund relates to donations received by the charity where the donor has stated they wish for the donations to be spent on the provision of physiotherapy services.

42

CHILTERNS NEURO CENTRE LTD. NOTES TO THE FINANCIAL STATEMENTS - CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024

24a ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS

£
Tangible fixed assets
2,372,677
Fixed asset investment
0
Current Assets
247,446
Creditors falling due within one year
(74,132)
Creditors falling due after more than one year
(95,796)
2,450,195
24b
£
2,452,529
Fixed asset investment
1,999
Current Assets
513,613
Creditors falling due within one year
(61,897)
Creditors falling due after more than one year
(117,367)
2,788,877
Unrestricted funds
Unrestricted funds
ANALYSIS OF GROUP NET ASSETS BETWEEN FUNDS
(PRIOR YEAR)		 Restricted
funds
£
0
0
354,943
0
0
354,943
Restricted
funds
£
0
0
130,002
0
0
130,002		 £
2,372,677
0
602,389
(74,132)
(95,796)
2,805,139
31
December
2023 Total
£
2,452,529
1,999
643,615
(61,897)
(117,367)
2,918,879

24 PENSION COMMITMENTS

During the year the charity contributed a total of £21,316 (2023: £19,312) to defined contribution schemes. This cost has been charged as an expense and analysed across activities in accordance with the allocation of the related employee salaries. At 31 December 2024, based on the employee salaries at the time, there was an annualised commitment of £22,830 (2022: £20,083).

25 RELATED PARTY DISCLOSURES

The total employee benefits of the key management personnel of the Group and Charity were £303,226(2023 £313,208). Key management personnel comprise the chief Executive officer together with the senior leadership team.

The charitable company has one subsidiary, Oakwood Wellbeing Limited as detailed in note 15 above. During the year, this subsidiary made payments under the gift aid payment scheme to the charitable company of £56,300 (2022: £64000).

26 ULTIMATE CONTROLLING PARTY

Chilterns Neuro Centre Ltd. is an incorporated charity under the control of the trustees collectively.

27 COMPANY LIMITED BY GUARANTEE

The liability of each member is limited to £10 by guarantee.

43

Chilterns Neuro Centre Ltd.

Oakwood Close, Wendover, Buckinghamshire HP22 5LX 01296 696133 | info@chilternsneurocentre.org www.chilternsneurocentre.org Registered charity no: 800853 | Registered company no: 02294557